Location History:
- New Castle, DE (US) (1992 - 1994)
- Wilmington, DE (US) (1996 - 2002)
Company Filing History:
11 out of 206 
3 out of 234 
2 out of 106 
Years Active: 1992-2002
Title: Gary A Cain: Innovator in Antipsychotic Pharmaceuticals
Introduction:
Gary A Cain is a prolific inventor and researcher, whose contributions in the field of pharmaceuticals have focused on developing novel compounds for the treatment of psychosis and related disorders. With eight patents to his name, Cain has made significant advancements in the development of antipsychotic drugs. This article provides an overview of his latest patents, career highlights, and collaborations.
Latest Patents:
1. Ether derivatives of alkyl piperidines and pyrrolidines as antipsychotic:
Gary A Cain's recent patent revolves around unsaturated ether derivatives of alkyl piperidine and pyrrolidine compounds. These compounds, along with the accompanying pharmaceutical compositions, hold promising potential as effective antipsychotic agents. The patent highlights novel methods of preparation and usage of these derivatives for treating psychosis effectively.
2. Treatment of psychosis using 1-cycloalkylpiperidines:
In this patent, Cain focuses on the development of cycloalkyl piperidine compounds that offer therapeutic benefits for physiological or drug-induced psychosis. These compounds function as selective sigma receptor antagonists, addressing the psychosis symptoms while minimizing the risk of movement disorder side effects commonly found in traditional antipsychotic agents.
Career Highlights:
Gary A Cain has a successful career path that demonstrates his commitment and expertise in pharmaceutical innovation. Currently associated with The DuPont Merck Pharmaceutical Company, Cain has contributed significantly to the advancements in antipsychotic medications.
Collaborations:
Throughout his career, Gary A Cain has collaborated with esteemed researchers and inventors in the field of pharmaceuticals. Two notable collaborators include:
1. Sang W Tam:
Sang W Tam, a renowned researcher, has worked closely with Cain on various projects related to antipsychotic drugs and treatment options. Their collaboration has led to fruitful outcomes, advancing the field and improving patient care.
2. Paul J Gilligan:
Paul J Gilligan, another esteemed researcher, has also collaborated with Cain on significant projects. Together, they have contributed to the development of innovative compounds and pharmaceutical compositions aimed at treating psychosis and related disorders.
Conclusion:
Gary A Cain's dedication to the field of pharmaceuticals and his numerous patents highlight his innovative contributions, specifically within the realm of antipsychotic medications. Through his discoveries and collaborations, Cain has paved the way for advanced treatment options, offering hope for individuals affected by psychosis and related conditions. His work stands as a testament to the power of innovation in improving healthcare and patient well-being.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.